# US 2023/0273200 A1 · Electrochemical immunosensor for detection of calprotectin

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0273200 A1
- Document ID: US20230273200A1
- Status: Published application
- Kind: A1
- Application number: 18/005,779
- Filed: 2021-08-11
- Published: 2023-08-31
- Earliest claimed: 2020-08-13
- Assignees: Eli Lilly and Company
- Applicants: Eli Lilly and Company
- Inventors: Muhammad Ashraful ALAM; Marco FRATUS; Rahim RAHIMI; Vidhya SELVAMANI; Mohit Singh VERMA; Jiangshan WANG
- Web page: https://patentgrep.com/patent/US20230273200A1

## CPC

- G01N 33/5438: {Electrodes}
- G01N 2333/4727: Calcium binding proteins, e.g. calmodulin
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

An electrochemical biosensor for detection of a calprotectin antigen in a sample solution. The electrochemical biosensor includes a reference electrode, a counter electrode, and a working electrode. The working electrode includes a surface coated with an anti-calprotectin antibody that binds to the calprotectin antigen in the sample solution. The electrochemical biosensor detects the concentration of the calprotectin antigen in the sample solution based on a resistance change at the surface of the working electrode.

## Claims

### Claim 1

An electrochemical biosensor for detection of a calprotectin antigen in a sample solution, the electrochemical biosensor comprising:
a reference electrode;
a counter electrode; and
a working electrode comprising a surface coated with an anti-calprotectin antibody configured to bind to the calprotectin antigen in the sample solution; and
wherein the biosensor is configured to detect a concentration of the calprotectin antigen in the sample solution based on a resistance change at the surface of the working electrode.

### Claim 2 (depends on 1)

The electrochemical biosensor of claim 1, wherein the reference electrode, the counter electrode, and the working electrode are formed on an electrode layer on the surface of a substrate.

### Claim 3 (depends on 1)

The electrochemical biosensor of claim 1, wherein the anti-calprotectin antibody comprises a thiolated mouse monoclonal anti-calprotectin antibody.

### Claim 4 (depends on 1)

The electrochemical biosensor of claim 1, wherein the surface of the working electrode is coated with an antibody solution of the anti-calprotectin antibody.

### Claim 5 (depends on 4)

The electrochemical biosensor of claim 4, wherein the concentration of the anti-calprotectin antibody in the antibody solution is 1 µg/mL to 20 µg/mL.

### Claim 6 (depends on 4)

The electrochemical biosensor of claim 4, wherein the concentration of the anti-calprotectin antibody in the antibody solution is 4 µg/mL to 6 µg/mL.

### Claim 7 (depends on 4)

The electrochemical biosensor of claim 4, wherein the concentration of the anti-calprotectin antibody in the antibody solution is 4.5 µg/mL to 5.5 µg/mL.

### Claim 8 (depends on 4)

The electrochemical biosensor of claim 4, wherein the concertation of the anti-calprotectin antibody in the antibody solution is 5 µg/mL.

### Claim 9 (depends on 4)

The electrochemical biosensor of claim 4, wherein the antibody solution consists of the anti-calprotectin antibody and a bovine serum.

### Claim 10 (depends on 1)

The electrochemical biosensor of claim 1, wherein the biosensor detects the concentration of the calprotectin antigen in the sample solution from 4 ng/mL to 240 ng/mL.

### Claim 11

A method of determining a concentration of a calprotectin antigen in a sample solution with a biosensor, the method comprising:
providing the biosensor comprising a reference electrode, a counter electrode, and a working electrode, the working electrode having a surface coated with an anti-calprotectin capture antibody;
providing the sample solution consisting essentially of the calprotectin antigen and lacking an anti-calprotectin detection antibody;
exposing the sample solution to the biosensor such that the calprotectin antigen binds to the anti-calprotectin capture antibody on the working electrode;
measuring a current between the counter electrode and the working electrode; and
determining the concentration of the calprotectin antigen in the sample solution based upon the measured current.

### Claim 12 (depends on 11)

The method of claim 11, wherein the current decreases as the concentration of the calprotectin antigen in the sample solution increases.

### Claim 13 (depends on 11)

The method of claim 11, wherein the surface of the working electrode is coated with an antibody solution of a thiolated form of the anti-calprotectin capture antibody at a concentration of 4 µg/ml to 6 µg/ml.

### Claim 14 (depends on 13)

The method of claim 13, wherein the concentration of the anti-calprotectin capture antibody in the antibody solution is 4.5 µg/ml to 5.5 µg/ml.

### Claim 15 (depends on 11)

The method of claim 11, wherein the concentration of the calprotectin antigen in the determining step is 4 ng/mL to 240 ng/mL.

### Claim 16

A system for detecting a concentration of a calprotectin antigen in a sample solution, the system comprising:
an electrochemical biosensor comprising a working electrode, a reference electrode, and a counter electrode, wherein an outer surface of the working electrode is coated with an anti-calprotectin antibody configured to bind to the calprotectin antigen in the sample solution; and
an analyzer in electrical communication with the biosensor and configured to determine a concentration of the calprotectin antigen in the sample solution from 4 ng/mL to 240 ng/mL based upon an electrical current flowing between the working electrode and the counter electrode.

### Claim 17 (depends on 16)

The system of claim 16, wherein the outer surface of the working electrode is coated with a solution of the anti-calprotectin antibody at a concentration of 4.5 µg/ml to 5.5 µg/ml.

### Claim 18 (depends on 17)

The system of claim 17, wherein the outer surface of the working electrode is coated with a 5 µg/ml solution of the anti-calprotectin antibody.

### Claim 19 (depends on 16)

The system of claim 16, wherein the analyzer is configured to associate the electrical current with a resistance change on the outer surface of the working electrode, and to correlate the resistance change with the concentration of the calprotectin antigen in the sample solution.

### Claim 20 (depends on 16)

The system of claim 16, wherein the working electrode is coated with a single type of the anti-calprotectin antibody.
